FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification What are peptides? FDA may ease restrictions on unproven health fad LiveNOW from FOX